Spectral imaging of deep tissue

• US 7,321,791 B2
• Filed: 09/23/2003
• Issued: 01/22/2008
• Est. Priority Date: 09/23/2003
• Status: Active Grant

• Current Assignee: Cambridge Research & Instrumentation Incorporated (Revvity, Inc.)
• Original Assignee: Cambridge Research & Instrumentation Incorporated (Revvity, Inc.)
• Inventors: Cronin, Paul J., Levenson, Richard
• Primary Examiner(s): Casler; Brian L.
• Assistant Examiner(s): KHOLDEBARIN, IMAN K
• Application Number:
  US10/669,101
• Publication Number:
  US 20050065440A1
• Time in Patent Office: 1,582 Days
• Field of Search: 600/310, 600/473, 600/476, 600/475, 600/477, 356/432, 356/433, 356/440
• US Class Current: 600/476
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: B82Y 10/00 Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• CPC Class Codes: G01J 3/32 Investigating bands of a spectrum in sequence by a single detector
• CPC Class Codes: G01J 3/4406 Fluorescence spectrometry
• CPC Class Codes: G01J 3/453 by correlation of the amplitudes
• CPC Class Codes: G01N 21/255 Details, e.g. use of specially adapted sources, lighting or optical systems
• CPC Class Codes: G01N 21/6486 Measuring fluorescence of biological material, e.g. DNA, RNA, cells G01N21/6428 takes precedence
• CPC Class Codes: G01N 2201/062 LED's
• CPC Class Codes: G01N 2201/125 Digital circuitry
• CPC Class Codes: G01N 33/4833 of solid biological material, e.g. tissue samples, cell cultures tissue in vivo A61B5/00; cell suspensions G01N33/48735

Abstract

Apparatus and methods are provided for the imaging of structures in deep tissue within biological specimens, using spectral imaging to provide highly sensitive detection. By acquiring data that provides a plurality of images of the sample with different spectral weightings, and subsequent spectral analysis, light emission from a target compound is separated from autofluorescence in the sample. With the autofluorescence reduced or eliminated, an improved measurement of the target compound is obtained.

Claims

1. A method comprising:

illuminating a sample to cause the sample to emit radiation, wherein the sample is a living mammal comprising deep tissue supporting a target compound, wherein the emitted radiation comprises emission from the target compound and emission from one or more other components in the sample, wherein the emission from the other components of the sample comprises autofluorescence from one or more layers of tissue in the sample different from a layer of tissue comprising the deep tissue, and wherein the deep tissue is subdermal tissue;

spectrally filtering the emitted radiation with each of at least four different spectral weighting functions;

storing an image of the spectrally filtered radiation for each of the spectral weighting functions; and

processing the stored images to construct a deep tissue image of the sample in which signal from the other compounds is reduced relative to signal from the target compound, wherein processing the stored images comprises constructing the deep tissue image based on a weighted superposition of information in the stored images and at least one emission spectrum for the other components in the sample.

2. The method of claim 1, wherein the animal comprises a mouse or a human.

3. The method of claim 1, wherein the deep tissue is an internal organ of the living mammal.

4. The method of claim 1, wherein the deep tissue lies within about 2 mm or more of the living mammal.

5. The method of claim 1, wherein the emission from the other components of the sample comprises autofluorescence from tissue overlying the deep tissue.

6. The method of claim 1, wherein the target compound is a fluorescent probe bound to at least a portion of the deep tissue.

7. The method of claim 1, wherein the target compound is a quantum dot bound to at least a portion of the deep tissue.

8. The method of claim 1, wherein the target compound is a green fluorescent protein (GFP) bound to at least a portion of the deep tissue.

9. The method of claim 1, wherein the target compound is a yellow fluorescent protein (YFP) bound to at least a portion of the deep tissue.

10. The method of claim 1, wherein the target compound is a red fluorescent protein (RFP) bound to at least a portion of the deep tissue.

11. The method of claim 1, wherein the emission from the target compound is fluorescence.

12. The method of claim 1, wherein at least some of the spectral weighting functions correspond to particular wavelength bands.

13. The method of claim 12, wherein all of the spectral weighting functions correspond to particular wavelength bands.

14. The method of claim 1, wherein at least some of the spectral weighting functions correspond to sinusoidal weightings of multiple wavelength bands.

15. The method of claim 1, wherein the spectral filtering comprises using a liquid-crystal, tunable optical filter.

16. The method of claim 1, wherein the spectral filtering comprises using an interferometric optical filter.

17. The method of claim 1, wherein the spectral filtering comprises using a filter wheel containing a plurality of band pass filters.

18. The method of claim 1, wherein each stored image comprises an intensity value for each of multiple pixels.

19. The method of claim 1, wherein constructing the deep tissue image comprises calculating a remainder spectrum for one or more pixels in the set of stored images.

20. The method of claim 1, wherein processing the stored images comprises constructing the deep tissue image based on the stored images, the at least one emission spectrum for the other components in the sample, and an emission spectrum for the target compound.

21. The method of claim 20, wherein constructing the deep tissue image comprises solving at least one component of a matrix equation in which one matrix is based on the stored images, and another matrix is based on the emission spectra.

22. The method of claim 1, wherein the deep tissue supports multiple target compounds and processing the stored images comprises constructing a deep tissue image for each of the target compounds.

23. The method of claim 22, wherein processing the stored images comprises constructing the deep tissue images based on the stored images and emission spectra for the target compounds.

24. The method of claim 23, wherein processing the stored images comprises constructing the deep tissue images based on the stored images, the emission spectra for the target compounds, and at least one emission spectrum for the other components in the sample.

25. The method of claim 1, wherein the emission comprises emission from a thickness of tissue at least 2 mm thick.

26. A method comprising:

providing at least four images of spectrally filtered radiation emitted from a sample that is a living mammal in response to an illumination,

wherein the sample comprises deep tissue supporting a target compound,

wherein the emitted radiation comprises emission from the target compound and emission from one or more other components in the sample,

wherein the emission from the other components of the sample comprises autofluorescence from one or more layers of tissue in the sample different from a layer of tissue comprising the deep tissue,

wherein the deep tissue is subdermal tissue, and

wherein each image corresponds to a different spectral weighting function; and

processing the images of the spectrally filtered radiation to construct a deep tissue image of the sample in which signal from the other compounds is reduced relative to signal from the target compound, and wherein processing the images comprises constructing the deep tissue image based on a weighted superposition of information in the stored images and at least one emission spectrum for the other components in the sample.

27. The method of claim 26, wherein the emission from the other components of the sample comprises autofluorescence from tissue overlying the deep tissue.

28. The method of claim 26, wherein the emission comprises emission from a thickness of tissue at least 2 mm thick.

29. The method of claim 26, wherein at least some of the spectral weighting functions correspond to particular wavelength bands.

30. The method of claim 29, wherein all of the spectral weighting functions correspond to particular wavelength bands.

31. The method of claim 26, wherein at least some of the spectral weighting functions correspond to sinusoidal weightings of multiple wavelength bands.

32. The method of claim 26, wherein constructing the deep tissue image comprises calculating a remainder spectrum for one or more pixels in the set of stored images.

33. The method of claim 26, wherein processing the stored images comprises constructing the deep tissue image based on the stored images, the at least one emission spectrum for the other components in the sample, and an emission spectrum for the target compound.

34. The method of claim 33, wherein constructing the deep tissue image comprises solving at least one component of a matrix equation in which one matrix is based on the stored images, and another matrix is based on the emission spectra.